Is this your firm? Get featured or correct your listing →
At a glance
Pear VC appears in 3 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was Forus' $150M Series C round (Sep 8, 2026).
Strategy
Recent changes
- Oct 14, 2026Oct 14, 2026Pear VC Closes $333M Fund V, Tops $1.1B AUM Pulse story
- Sep 8, 2026Sep 8, 2026Invested in Forus (Series C, $150M) Bloomberg
- Aug 13, 2026Aug 13, 2026Invested in Vals AI (Series A, $40M) Tech Funding News
- Aug 11, 2026Aug 11, 2026Invested in Infinimmune (Series A, $75M) Business Wire (via FinancialContent)
Portfolio
3 totalRecent Investment Activity
3Track record: led 0 and participated in 3 of 3 tracked venture rounds · 3 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Forus | Series C | Participated | $150M | $3B | Bloomberg | |
| Aug 13, 2026 | Vals AI | Series A | Participated | $40M | $400M | Tech Funding News | |
| Aug 11, 2026 | Infinimmune | Series A | Participated | $75M | — | Regeneron VenturesLeadMedCity NewsPlayground GlobalLeadunverifiedMerck Global Health Innovation FundMedCity NewsCivilization VenturesMedCity NewsPear VCMedCity NewsRA CapitalunverifiedGoldcrest CapitalunverifiedGodfrey CapitalunverifiedEverbright BiofundForge Life Science PartnersWild Tree Ventures | Pulse story |
Sector / Stage Activity
Co-Investors
12Similar Firms
overlapping sector, stage or regionValue Add Research
Latest Pulse
- Oct 14, 2026Pear VC Closes $333M Fund V, Tops $1.1B AUMPear VC closed its $333 million Fund V, pushing total assets under management past $1.1 billion as the pre-seed and seed investor promotes three internal partners to general partner.→
- Oct 5, 2026Five Startups Stood Out At PearX Demo DayFive early-stage companies -- from an on-device AI inference chip to an AI-native trust company -- stood out to investors at Pear VC's latest PearX demo day, spanning robotics, personal AI, estate planning and industrial design.→
- Sep 9, 2026Listen Labs Ditches Term Sheet For Salesforce DealListen Labs walked away from a signed $125 million Series C term sheet at a $1.5 billion valuation to pursue a sale to Salesforce reportedly worth around $2 billion; Salesforce signed a definitive agreement to acquire the company on September 29 without disclosing the price.→
- Sep 8, 2026Forus Triples Valuation To $3B In Series CForus raised a $150 million Series C led by Bain Capital Ventures at a $3 billion valuation, tripling its worth months after its Series B, as its AI agents automate prescription prior authorization for providers nationwide.→
- Sep 8, 2026Forus Triples to a $3B Value in Four MonthsForus, an AI network that automates prescription access between doctors, pharmacies and payers, raised $150 million at a $3 billion valuation -- roughly triple its mark from four months ago.→
- Aug 11, 2026Infinimmune Raises $75M for Human-Derived Antibody DrugsInfinimmune raised a $75 million Series A co-led by Regeneron Ventures and Playground Global to advance two atopic dermatitis antibody candidates built from its human-derived Anthrobody platform.→
Pear VC FAQ
What companies has Pear VC invested in?
Pear VC's portfolio includes Forus, Vals AI, Infinimmune.
Who does Pear VC co-invest with most?
In the rounds Value Add tracks, Pear VC most often invests alongside 8VC (1 shared deal), Accel (1 shared deal), Andreessen Horowitz (1 shared deal), Bain Capital Ventures (1 shared deal), Bloomberg Beta (1 shared deal).
Sources & methodologyshow
- Bloombergmajor outlet1 fact
- Business Wire (via FinancialContent)research database1 fact
- Tech Funding NewsValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.